Type:Notice
Citation:90 FR 596
Reading Time:about a minute or two
Sanofi US Services Inc. has asked the Foreign-Trade Zones Board for permission to start production of pharmaceutical products at its facilities in Ridgefield, New Jersey, within FTZ 49. Specifically, they plan to produce Beyfortus® (Nirsevimab), a vaccine that will be duty-free. The materials needed for this production also include the duty-free Beyfortus® monoclonal antibody active ingredient. The public is invited to comment on this proposal by February 18, 2025, by sending an email to the Board's Executive Secretary.
Simple Explanation
Sanofi wants permission to make a special vaccine in New Jersey where they don't have to pay extra taxes, and they are asking people to email their thoughts about this by February 18, 2025.